Milestone Securitisation definition

Milestone Securitisation means that point in time when the ESCo receives its funds from the Assignee.

Examples of Milestone Securitisation in a sentence

  • After financing of appropriate funds via Milestone Securitisation, the applicable floating interest rate for those financed funds will be based upon the Bank Prime interest rate selected by the ESCo as published in the Globe and Mail newspaper at the end of each month plus the Financier Floating Interest Rate Premium identified by the ESCo in its proposal.

  • During construction and prior to financing of appropriate funds via Milestone Securitisation, the applicable Nominal Interest Rate will be a floating rate based upon the Bank Prime interest rate selected by the ESCo as published in the Globe and Mail newspaper at the end of each month plus the Company Floating Interest Rate Premium identified by the ESCo in its proposal.

  • See Specific Instructions for more information.• Date of merger fields have been added to Step 1 of the 2014 Schedule UB.

Related to Milestone Securitisation

  • securitisation means a transaction or scheme, whereby the credit risk associated with an exposure or pool of exposures is tranched, having both of the following characteristics:

  • securitisation position means an exposure to a securitisation;

  • Dynamic driving task means the same as that term is defined in Section 41-26-102.1.

  • Milestone Event has the meaning set forth in Section 8.4.

  • Programme means any television broadcast and includes-

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Learning Programme means a programme of education and/or training delivered by the Provider under this Agreement;

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • spatial development framework means the Engcobo Municipal Spatial Development Framework prepared and adopted in terms of sections 20 and 21 of the Act and Chapter 2 of this By-Law;

  • Integrated pest management means careful consideration of all available plant protection methods and subsequent integration of appropriate measures that discourage the development of populations of harmful organisms and keep the use of plant protection products and other forms of intervention to levels that are economically and ecologically justified and reduce or minimise risks to human health and the environment. ‘Integrated pest management’ emphasises the growth of a healthy crop with the least possible disruption to agro-ecosystems and encourages natural pest control mechanisms;

  • Grenfell Tower support payment means a payment made to a person because that person was affected by the fire on 14th June 2017 at Grenfell Tower, or a payment to the personal representative of such a person—

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Stage means level of progress of the works identified as such and more particularly described in the Employer’s Requirements for which a Key Date for the achievement thereof is stipulated in the Contract.

  • Expiry Date (Data di Scadenza) means the Expiry Date as specified in § 1 of the Product and Underlying Data.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • the Scottish Infected Blood Support Scheme means the scheme of that name administered by the Common Services Agency (constituted under section 10 of the National Health Service (Scotland) Act 1978(b));

  • Additional SDU Study means a deliverability study that a Developer may elect to pursue as that term is defined in OATT Section 25 (OATT Attachment S). For purposes of Section 23.4.5 of this Attachment H, “Affiliated Entity” shall mean, with respect to a person or Entity:

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.